featured-image

RUNSTUDIO/DigitalVision via Getty Images Exscientia ( NASDAQ: EXAI ) said it would let go of 20%-25% of its staff by the end of the year, particularly in target identification, precision medicine, experimentation, engineering, and infrastructure. Shares are down ~10% in Tuesday morning trading. The company expects to incur severance and termination costs of $7.

4M-$9.6M that will be recorded this quarter but paid through the remainder of 2024. Along with other measures, Exscientia (EXAI) expects annualized savings of at least $40M beginning in 2025.



The company added it now projects its cash runway will extend into 2027. More on Exscientia Exscientia plc (EXAI) Q4 2023 Earnings Call Transcript Exscientia: A Strategic Hold In The AI-Driven Drug Discovery Sector (Rating Downgrade) Exscientia FY 2023 Earnings Preview Anagenex expands leadership team with appointment of Adrian Schreyer as CTO Seeking Alpha’s Quant Rating on Exscientia.

Back to Health Page